GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Pharmaniaga Bhd (XKLS:7081) » Definitions » Debt-to-Revenue

Pharmaniaga Bhd (XKLS:7081) Debt-to-Revenue : 0.30 (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Pharmaniaga Bhd Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Pharmaniaga Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was RM1,123 Mil. Pharmaniaga Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was RM116 Mil. Pharmaniaga Bhd's annualized Revenue for the quarter that ended in Sep. 2024 was RM4,119 Mil. Pharmaniaga Bhd's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.30.


Pharmaniaga Bhd Debt-to-Revenue Historical Data

The historical data trend for Pharmaniaga Bhd's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaniaga Bhd Debt-to-Revenue Chart

Pharmaniaga Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.25 0.18 0.34 0.35

Pharmaniaga Bhd Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.38 0.32 0.36 0.30

Competitive Comparison of Pharmaniaga Bhd's Debt-to-Revenue

For the Medical Distribution subindustry, Pharmaniaga Bhd's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaniaga Bhd's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Debt-to-Revenue falls into.



Pharmaniaga Bhd Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Pharmaniaga Bhd's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1051.67 + 139.713) / 3404.481
=0.35

Pharmaniaga Bhd's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1123.01 + 115.702) / 4119.288
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Pharmaniaga Bhd Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharmaniaga Bhd's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaniaga Bhd Business Description

Traded in Other Exchanges
N/A
Address
No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia, and Other countries, of which key revenue is derived from Malaysia.

Pharmaniaga Bhd Headlines

No Headlines